Cargando…
Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9
The development of high efficiency, central nervous system (CNS) targeting AAV-based gene therapies is necessary to address challenges in both pre-clinical and clinical investigations. The engineered capsids, AAV.PHP.B and AAV.PHP.eB, show vastly improved blood-brain barrier penetration compared to...
Autores principales: | Chatterjee, Diptaman, Marmion, David J., McBride, Jodi L., Manfredsson, Fredric P., Butler, David, Messer, Anne, Kordower, Jeffrey H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203269/ https://www.ncbi.nlm.nih.gov/pubmed/33753910 http://dx.doi.org/10.1038/s41434-021-00244-y |
Ejemplares similares
-
A Single Cisterna Magna Injection of AAV Leads to Binaural Transduction in Mice
por: Blanc, Fabian, et al.
Publicado: (2022) -
CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain
por: Mathiesen, Sophie N., et al.
Publicado: (2020) -
Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
por: Kanaan, Nicholas M., et al.
Publicado: (2017) -
Structural basis for the neurotropic AAV9 and the engineered AAVPHP.eB recognition with cellular receptors
por: Xu, Guangxue, et al.
Publicado: (2022) -
Widespread gene transfer in the central nervous system of cynomolgus macaques following delivery of AAV9 into the cisterna magna
por: Hinderer, Christian, et al.
Publicado: (2014)